Universal Ibogaine Inc. (IBOGF)
| Market Cap | 1.14M -73.2% |
| Revenue (ttm) | 1.49M -11.7% |
| Net Income | -1.07M |
| EPS | -0.00 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20,000 |
| Open | 0.0252 |
| Previous Close | 0.0207 |
| Day's Range | 0.0237 - 0.0252 |
| 52-Week Range | 0.0023 - 0.3500 |
| Beta | 4.34 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jan 26, 2027 |
About Universal Ibogaine
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. The company also undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine Inc. is headquartered in Calgary, Canada. [Read more]
Financial Performance
In fiscal year 2024, Universal Ibogaine's revenue was 2.33 million, an increase of 126.32% compared to the previous year's 1.03 million. Losses were -2.05 million, -14.17% less than in 2023.
Financial numbers in CAD Financial StatementsNews
Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process
Calgary, AB – TheNewswire - January 19, 2026 – Universal Ibogaine Inc. ( TSXV:IBO) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addicti...
Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process
Calgary, AB – TheNewswire - December 18, 2025 – Universal Ibogaine Inc. ( TSXV:IBO) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addict...
Universal Ibogaine advises further on application for Management Cease Trade Order
Calgary, AB – December 2, 2025 – TheNewswire – Universal Ibogaine Inc. ( TSXV:IBO) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized ibogaine-cen...
Universal Ibogaine Advises of Filing Application for Management Cease Trade Order
Calgary, AB – TheNewswire - November 25, 2025 – Universal Ibogaine Inc. ( TSXV:IBO) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addict...
Universal Ibogaine Provides Corporate Update
Calgary, AB – TheNewswire - October 28, 2025 – Universal Ibogaine Inc. ( TSXV:IBO) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized ibogaine-cen...
Universal Ibogaine Provides Update on Status of Current Cease Trade Order
Calgary, AB – February 5, 2025 – TheNewswire - Universal Ibogaine Inc. ( TSXV:IBO) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addicti...
Universal Ibogaine Co-Founder Dr Alberto Sola to Present at upcoming Research to Reality Conference
CALGARY, AB , May 13, 2022 /PRNewswire/ - Universal Ibogaine Inc. (TSXV: IBO) (OTCQB: IBOGF) (FSE: JC4) ("UI" or the "Company") a life sciences company with a mission to transform addiction treatment ...
UNIVERSAL IBOGAINE RETAINS SHAYNE NYQUVEST AS CAPITAL MARKETS ADVISOR
CALGARY, AB , April 29, 2022 /PRNewswire/ - Universal Ibogaine Inc. (TSXV: IBO) (OTCQB: IBOGF) (FSE: JC4) ("UI" or the "Company") a life sciences company with a mission to develop and deliver medicali...
UNIVERSAL IBOGAINE PROVIDES UPDATE ON KELBURN RECOVERY CENTER OPERATIONS
CALGARY, AB , April 7, 2022 /PRNewswire/ - Universal Ibogaine Inc. (TSXV: IBO) ("UI" or the "Company") a life sciences company with a mission to develop and deliver medicalized ibogaine-centered addic...
Universal Ibogaine Announces Frankfurt Stock Exchange Listing
CALGARY, AB , April 6, 2022 /PRNewswire/ - Universal Ibogaine Inc. (TSXV: IBO) (OTCQB: IBOGF) (FSE: JC4) ("UI" or the "Company") a life sciences company with a mission to transform the world of addict...